Filing Details
- Accession Number:
- 0001293301-14-000005
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-01-24 16:58:13
- Reporting Period:
- 2014-01-22
- Filing Date:
- 2014-01-24
- Accepted Time:
- 2014-01-24 16:58:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 38074 | Forest Laboratories Inc | FRX | Pharmaceutical Preparations (2834) | 111798614 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1509230 | Jerome Lynch | C/O Forest Laboratories, Inc. 909 Third Avenue New York NY 10022 | Svp-Sales | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-01-22 | 15,000 | $42.54 | 81,577 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-01-22 | 25,000 | $51.54 | 106,577 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-01-22 | 12,500 | $37.26 | 119,077 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-01-22 | 20,000 | $24.12 | 139,077 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-01-22 | 12,000 | $31.27 | 151,077 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-01-22 | 22,500 | $32.17 | 173,577 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-01-22 | 22,700 | $30.00 | 196,277 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-01-22 | 5,925 | $34.04 | 202,202 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-01-22 | 135,625 | $67.28 | 66,577 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-01-22 | 15,000 | $0.00 | 15,000 | $42.54 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-01-22 | 25,000 | $0.00 | 25,000 | $51.54 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-01-22 | 12,500 | $0.00 | 12,500 | $37.26 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-01-22 | 20,000 | $0.00 | 20,000 | $24.12 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-01-22 | 12,000 | $0.00 | 12,000 | $31.27 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-01-22 | 22,500 | $0.00 | 22,500 | $32.17 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-01-22 | 22,700 | $0.00 | 22,700 | $30.00 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-01-22 | 5,925 | $0.00 | 5,925 | $34.04 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2005-12-13 | 2014-12-13 | No | 4 | M | Direct |
| 0 | 2007-12-07 | 2016-12-08 | No | 4 | M | Direct |
| 0 | 2008-12-06 | 2017-12-05 | No | 4 | M | Direct |
| 0 | 2009-12-08 | 2018-12-08 | No | 4 | M | Direct |
| 8,000 | 2010-12-07 | 2019-12-06 | No | 4 | M | Direct |
| 27,500 | 2011-12-06 | 2020-12-05 | No | 4 | M | Direct |
| 22,700 | 2012-12-05 | 2021-12-04 | No | 4 | M | Direct |
| 17,775 | 2013-05-07 | 2022-05-06 | No | 4 | M | Direct |
Footnotes
- This amount includes shares of common stock which are subject to a risk of forfeiture.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.00 to $67.66, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- Not Applicable.
Billionaire Hedge Funds
